Stockreport

Akorn Receives Approval for Mycophenolate Mofetil for Injection, USP

AKORN  (AKRX) 
Last akorn earnings: 10/31 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.akorn.com
PDF LAKE FOREST, Ill., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty pharmaceutical company, today announced that it has received approv [Read more]